Skip to main content

Table 3 Maximum voluntary muscle strength (Newton [N]). Baseline data and percentage change after 12 months of treatment according to group allocation. Median with interquartile range (25–75 % percentiles)

From: The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial

Muscle group

 

P-value

 

P-value*

Baseline (Newton)

Change after 12 months (%)

Hand grip

 

0.79

 

0.58

 Placebo

287 (257;311)

 

−0.18 (−7.02;6.78)

 

 Melatonin

281 (244;333)

 

−0.75 (−10.40;7.59)

Elbow extension

 

0.23

 

0.74

 Placebo

116 (98;138)

 

6.21 (1.23;12.85)

 Melatonin

111 (92;121)

 

5.20 (−3.51;15.28)

Elbow flexion

 

0.18

 

0.37

 Placebo

178 (156;192)

 

1.95 (−6.77;10.75)

 Melatonin

165 (152;185)

 

−1.45 (−9.12;6.91)

Knee extension 90°

0.67

 

0.99

 Placebo

309 (278;377)

 

0.33 (−2.68;5.44)

 Melatonin

312 (275;357)

 

0.55 (−6.66;11.26)

Knee flexion 90°

 

0.40

 

0.93

 Placebo

160 (137;177)

 

0.26 (−7.13;16.89)

 Melatonin

153 (121;177)

 

0.00 (−6.09;13.79)

Knee extension 60°

0.26

 

0.33

 Placebo

384 (326;433)

 

0.76 (−4.08;4.16)

 Melatonin

370 (313;410)

 

1.73 (−5.94;10.49)

Knee flexion 60°

 

0.44

 

0.54

 Placebo

169 (139;203)

 

4.31 (−9.61;22.58)

 Melatonin

163 (138;182)

 

0.99 (−2.53;9.66)

  1. *Significant changes between groups